U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06804395) titled 'CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management' on Jan. 17.
Brief Summary: Early diagnosis of cancer allows for better treatment outcomes, higher survival rates, and lower costs of care. It is shown that cancer monitoring for cancer in at-risk populations is a key component in early diagnosis. The HMH Hennessey Institute for Cancer prevention and Applied Molecular Science (HICAP) is a newly founded institute, providing clinical services for cancer screening and risk assessment to the community, as well as research in cancer risk and prevention. The CanScan registry will...